Gland Pharma (NSE:GLAND) Price-to-Operating-Cash-Flow : (As of May. 16, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gland Pharma Price-to-Operating-Cash-Flow?

As of today (2024-05-16), Gland Pharma's share price is ₹1779.65. Gland Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00. Hence, Gland Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Gland Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

NSE:GLAND' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 77.37 Med: 116.29 Max: 891.31
Current: 77.37

During the past 6 years, Gland Pharma's highest Price-to-Operating-Cash-Flow Ratio was 891.31. The lowest was 77.37. And the median was 116.29.

NSE:GLAND's Price-to-Operating-Cash-Flow is ranked worse than
92.47% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.48 vs NSE:GLAND: 77.37

Gland Pharma's Cash Flow from Operations per share for the three months ended in Dec. 2023 was ₹0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -19.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 22.50% per year.

During the past 6 years, Gland Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 61.80% per year. The lowest was -19.90% per year. And the median was 45.60% per year.

Gland Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Gland Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gland Pharma Price-to-Operating-Cash-Flow Chart

Gland Pharma Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

64.84

68.10

57.38

Gland Pharma Quarterly Data
	Mar18	Mar19	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	57.38	-	-	-

Competitive Comparison of Gland Pharma's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - General subindustry, Gland Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gland Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gland Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Gland Pharma's Price-to-Operating-Cash-Flow falls into.

Gland Pharma Price-to-Operating-Cash-Flow Calculation

Gland Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	1779.65	/	0
	=

Gland Pharma's Share Price of today is ₹1779.65.
Gland Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Gland Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Gland Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Gland Pharma (NSE:GLAND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gland Pharma Ltd (NSE:GLAND) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

543245:India

Address

Plot No. 11 and 84, TSIIC Phase: IV, Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, TG, IND, 502307

Website

https://www.glandpharma.com

Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Further, the group is involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

Gland Pharma (NSE:GLAND) Headlines

No Headlines